SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 247 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,478 | -13.1% | 616 | +10.8% | 0.00% | – |
| Q1 2024 | $18,965 | +28.8% | 556 | +9.2% | 0.00% | – |
| Q4 2023 | $14,730 | +13.3% | 509 | +7.8% | 0.00% | – |
| Q3 2023 | $13,000 | -7.1% | 472 | +3.1% | 0.00% | – |
| Q2 2023 | $14,000 | -22.2% | 458 | -6.7% | 0.00% | – |
| Q1 2023 | $18,000 | 0.0% | 491 | -1.4% | 0.00% | – |
| Q4 2022 | $18,000 | -57.1% | 498 | -60.3% | 0.00% | – |
| Q3 2022 | $42,000 | +61.5% | 1,253 | +41.6% | 0.00% | – |
| Q2 2022 | $26,000 | +100.0% | 885 | +112.7% | 0.00% | – |
| Q1 2022 | $13,000 | -98.9% | 416 | -99.1% | 0.00% | -100.0% |
| Q4 2020 | $1,189,000 | +56.4% | 47,258 | +29.5% | 0.01% | +25.0% |
| Q3 2020 | $760,000 | -3.6% | 36,479 | +27.1% | 0.00% | 0.0% |
| Q3 2019 | $788,000 | +163.5% | 28,691 | +217.3% | 0.00% | +100.0% |
| Q2 2019 | $299,000 | – | 9,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |